Signaling Activation and Modulation in Extrafollicular B Cell Responses

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• B cell differentiation into germinal center (GC) or extrafollicular (EF) pathways dictates effector B cell characteristics and autoreactive B cell selection.
• Early signaling events post-antigen encounter integrate activating and inhibitory signals to guide B cell fate.
• The PI3K/AKT/mTOR pathway is central to modulating these early signaling events and determining B cell developmental decisions.

Purpose of the Study:

• To review signaling events in newly activated B cells, focusing on the PI3K/AKT/mTOR pathway's role.
• To highlight the regulation of the PI3K/AKT/mTOR pathway in B cell differentiation.
• To discuss the implications of dysregulated signaling in autoimmunity and inborn errors of immunity (IEIs).

Main Methods:

• This review synthesizes existing literature on B cell signaling pathways.
• Focuses on the PI3K/AKT/mTOR pathway's induction and regulation.
• Examines the physiological context and consequences of aberrant signaling in autoimmune diseases and IEIs.

Main Results:

• Early B cell signaling integrates signals from T cells, TLRs, and cytokines, modulated by inhibitory receptors.
• The PI3K/AKT/mTOR pathway's intensity influences the choice between GC maturation and rapid EF differentiation into antibody-secreting cells (ASCs).
• Aberrant PI3K/AKT/mTOR signaling is linked to defective autoreactive B cell selection and increased autoimmunity risk.

Conclusions:

• Proper regulation of PI3K/AKT/mTOR signaling is essential for maintaining B cell homeostasis and preventing autoimmunity.
• Dysregulation disrupts the balance of GC and EF fates, contributing to autoimmune conditions.
• Further research is needed to fully understand the regulation of alternative B cell fates and their role in immunity and disease.